Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Bioavailability of a Formulation of Duloxetine 60 mg Capsules With Enteric Coated Granules With Regards to the Marketed Reference Product

NCT04723238 is registered in ClinicalTrials.gov with Laboratorios Andromaco S.A. as lead sponsor.

NCT NCT04723238
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04723238 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Bioavailability of a Formulation of Duloxetine 60 mg Capsules With Enteric Coated Granules With Regards to the Marketed Reference Product
Lead sponsor
Laboratorios Andromaco S.A.
Phase
Phase 1
Overall status
Completed
Start date
January 23, 2021
Completion date
March 26, 2021
Enrollment
36 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

bioequivalence